Anaheim, CA, United States of America

Janet A Takeuchi

USPTO Granted Patents = 37 


 

Average Co-Inventor Count = 4.0

ph-index = 3

Forward Citations = 23(Granted Patents)


Location History:

  • Anaheim, CA (US) (2005 - 2015)
  • Irvine, CA (US) (2016)

Company Filing History:


Years Active: 2005-2016

Loading Chart...
Loading Chart...
Loading Chart...
37 patents (USPTO):Explore Patents

Title: Innovations and Achievements of Janet A. Takeuchi

Introduction

Janet A. Takeuchi is a distinguished inventor based in Anaheim, California, with an impressive portfolio of 37 patents to her name. Her groundbreaking work primarily focuses on pharmaceutical innovations, particularly in the area of sphingosine-1-phosphate receptor modulation, which has significant implications for various therapeutic applications.

Latest Patents

Among her latest patents, Janet has developed bicyclic 1,3,4-oxadiazole derivatives designed as modulators of sphingosine-1-phosphate receptors. This invention entails processes for preparing these derivatives, the pharmaceutical compositions containing them, and their potential uses in medical treatments. Additionally, she has also innovated in the realm of substituted 1,3,4-oxadiazoles-2-thio azetidine derivatives, which serve a similar purpose in modulating sphingosine-1-phosphate receptors, highlighting her commitment to advancing pharmaceutical science.

Career Highlights

Janet A. Takeuchi currently works at Allergan, Inc., a renowned global pharmaceutical company known for its contributions to various therapeutic fields. Her work has not only resulted in numerous patents but has also placed her at the forefront of research and development within her industry.

Collaborations

Throughout her career, Janet has collaborated with distinguished colleagues, including Ling Li and Ken Chow. These collaborations have allowed for a synergistic approach to innovation, fostering an environment where novel ideas and solutions to complex problems can flourish.

Conclusion

In summary, Janet A. Takeuchi exemplifies the spirit of innovation in the pharmaceutical field. With her innovative patents and collaborative efforts at Allergan, Inc., she is poised to make significant advancements in the modulation of sphingosine-1-phosphate receptors, ultimately contributing to the betterment of healthcare solutions. Her dedication to research and development continues to inspire and pave the way for future inventions.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…